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Abstract
Apoptosis-associated tyrosine kinase 1 (AATYK1), a novel serine/threonine kinase that is highly expressed in the brain, is
involved in neurite extension and apoptosis of cerebellar granule neurons; however, its precise function remains unknown.
In this study, we investigated the interaction of AATYK1A with Cyclin-dependent kinase 5 (Cdk5)/p35, a proline-directed
protein kinase that is predominantly expressed in neurons. AATYK1A bound to the p35 activation subunit of Cdk5 in
cultured cells and in mouse brains and colocalized with p35 on endosomes in COS-7 cells. AATYK1A was phosphorylated at
Ser34 by Cdk5/p35 in vitro, in cultured neurons and in mouse brain. In PC12D cells, Ser34 phosphorylation increased after
treatment with nerve growth factor and phosphorylated AATYK1A accumulated in growth cones of PC12D cells. Ser34
phosphorylation suppressed the tyrosine phosphorylation of AATYK1A by Src family kinases. These results suggest a
possibility that AATYK1A plays a role in early to recycling endosomes and its function is regulated by phosphorylation with
Cdk5 or Src-family kinases.
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Introduction
Apoptosis-associated tyrosine kinases (AATYKs) are a family of
protein kinases comprising AATYK1–3 [1]. AATYK1, which was
originally isolated, was termed after its increased expression in
myeloid precursor cells undergoing apoptosis and its sequence
homology to receptor-type tyrosine kinase [2]. However, all
AATYK-family kinases are now considered as Ser/Thr kinases
that are expressed abundantly in the brain [3,4,5,6]. AATYK1
expresses two splice variants (AATYK1A and AATYK1B) that
differ on the presence of the amino-terminal transmembrane
sequence of AATYK1B, which is located upstream of the amino-
terminal of AATYK1A [1]. AATYK1A comprises 1,317 amino
acids and includes an amino-terminal kinase domain and a long
carboxy-terminal tail domain. AATYK1 is also known as lemur
tyrosine kinase 1 (LMTK1), based on its long carboxy-terminal tail
region [7]. Although AATYK1 is involved in neurite extension
and low K
+-induced apoptosis in cerebellar granule neurons [8,9],
its precise neuronal function remains elusive.
Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/
threonine (Ser/Thr) kinase that is activated by activation subunits
p35 or p39, which are predominantly expressed in neurons
[10,11]. Cdk5/p35 plays a role in a variety of neuronal activities,
including neuronal migration, neurite extension, endocytic
pathway, synaptic plasticity, and neuronal death in neurodegen-
erative diseases [12,13,14]. We reported the binding of the short
isoform of AATYK1 to p35 and its phosphorylation by Cdk5 in
vitro and in cultured cells [15]; however, the interaction of
AATYK1A, the major isoform in neurons, with Cdk5/p35 has not
been examined. Furthermore, the phosphorylation site and the
role of phosphorylation have not been addressed. In addition, we
reported recently that AATYK1A associates with recycling
endosomes via palmitoylation at the amino-terminal region [16].
This cellular localization is different from that of Cdk5/p35, which
reportedly localizes to the Golgi apparatus and plasma membrane
[17,18]. Thus, the interaction of AATYK1A with Cdk5/p35
warrants more detailed examination. Here, we investigated the
interaction, binding, and colocalization of AATYK1A with Cdk5/
p35 in HEK293 cells, COS-7 cells, PC12D cells, rat brain cortical
neurons and mouse brain. We also assessed the Cdk5/p35
phosphorylation site on AATYK1A, as well as its function.
Results
Association of AATYK1A with p35 on endosomes in
cultured cells
AATYK1A tagged with Flag was coexpressed with Cdk5 and/
or p35 in HEK293 cells and immunoprecipitated with an anti-
Flag antibody from extracts of these cells. Both p35 and Cdk5
were detected in the immunoprecipitates when Cdk5 and p35
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in the immunoprecipitates in the absence of p35 (Fig. 1A, lane 4).
Immunoprecipitation of p35 in the absence of Cdk5 has been
shown previously (15). All these results indicate that AATYK1A
binds to p35 but not to Cdk5. In vivo association is shown in
Figure 1B. Both p35 and Cdk5 were detected in the immunopre-
cipitates obtained from brain extracts using the anti-AATYK1
antibody (Fig. 1B, lane 3).
We compared the cellular distribution of AATYK1A with that of
p35 in COS-7 cells coexpressing both proteins, as their differential
localization has been reported, i.e., Cdk5/p35 at the Golgi apparatus
and plasma membrane [17,18,19] and AATYK1A mainly at
recycling endosomes [16]. The coexpression of AATYK1A and
p35 in COS-7 cells led to a punctate staining for p35 in the
perinuclear region and cell periphery (Fig. 2A, left panel), as reported
previously [17,18,19]. AATYK1A also exhibited localization in
perinuclear regions (Fig. 2A, middle panel). Higher magnification of
the perinuclear region is shown in insets. The merged image depicts
their colocalization clearly (arrows in insets of Fig. 1A). To determine
whether these proteins were both present in endosomes, AATYK1A
and p35 were coexpressed with the endosomemarkers EGFP-Rab5A
(for early endosomes) and EGFP-Rab11A (for recycling endosomes)
(Fig. 2B). AATYK1A and p35 both colocalized with early and
recycling endosomes, which were labeled with Rab5A and Rab11A,
respectively. These data indicate that AATYK1A associates with p35
in early and recycling endosomes in COS-7 cells.
Localization of AATYK1A and p35 in recycling endosomes was
next examined in neurons. At first, we tested the localization of
exogenously expressed p35 in recycling endosomes using Alexa
546-transferrin (Tf), which is transported to recycling endosomes
when incorporated into cells. At 2 h after treatment, Tf
accumulated at the perinuclear region, where p35 was strongly
labeled (data not shown). To further confirm the localization of
endogenous AATYK1A and p35 in recycling endosomes, we
compared the staining with anti-AATYK1 or anti-p35 antibodies
with EGFP-Rab11A transfected. Rab11A was detected at the
perinuclear regions (Fig. 2C) as was reported previously [20]. Both
AATYK1A and p35 showed stronger staining at the perinuclear
region, and some of them were overlapped with Rab11A (Fig. 2C),
indicating the localization of AATYK1 and p35 in recycling
endosomes in neurons.
Phosphorylation of AATYK1A at Ser34 by Cdk5
As shown in lane 5 of Figure 1A, AATYK1A exhibited a slower
mobility on SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
when coexpressed with Cdk5/p35 in HEK293 cells. This result
suggests that full-length AATYK1A was phosphorylated by Cdk5/
p35. To confirm this hypothesis, we incubated AATYK1A with
purified Cdk5/p35 in vitro in the presence of [c-
32P]ATP.
AATYK1A was labeled strongly with
32P after incubation with
Cdk5/p35 (Fig. 3A, lane 5) and this labeling was inhibited by
roscovitine, which is a Cdk5 inhibitor (Fig. 3A, lane 6). Cellular
phosphorylation was also examined in HEK293 cells cotransfected
with AATYK1A and Cdk5/p35. The upward shift of AATYK1A
induced by cotransfection with Cdk5/p35 was reversed by
alkaline-phosphatase treatment (Fig. 3B, lanes 3 and 4), which
suggests that the upward shift of AATYK1A is due to Cdk5/p35-
mediated phosphorylation.
To identify the Cdk5/p35 phosphorylation site of AATYK1A,
we coexpressed several AATYK1A carboxy-terminal truncation
mutants in HEK293 cells with Cdk5/p35 and examined their
phosphorylation by band shift (Fig. 3C). All truncation mutants,
i.e., AATYK1A amino-acid residues 1–1130 (N1130), 1–667
(N667), and 1–530 (N530), were shifted upward after cotransfec-
tion with Cdk5/p35, which suggests the presence of a Cdk5
phosphorylation site in the amino-terminal region of AATYK1A.
There are five (Ser/Thr)Pro Cdk5 consensus phosphorylation
sequences in N530. We were interested in Ser34, which is the only
Figure 1. Binding of AATYK1A to Cdk5/p35. (A) Coimmunoprecipitation of Cdk5/p35 with AATYK1A in HEK293 cells. AATYK1A-Flag was
coexpressed with p35 and/or Cdk5 in HEK293 cells and immunoprecipitated from cell lysates using the anti-Flag antibody. p35 and Cdk5 were
detected in the anti-Flag immunoprecipitates by immunoblotting using anti-p35 and anti-Cdk5 antibodies. (B) Coimmunoprecipitation of Cdk5/p35
from mouse brain extracts using the anti-AATYK1 antibody. AATYK1 was immunoprecipitated from a mouse brain extract (10 weeks). p35 and Cdk5
were detected in the AATYK1 immunoprecipitates using the anti-p35 and anti-Cdk5 antibodies.
doi:10.1371/journal.pone.0010260.g001
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because the region includes several functional amino acids, which
include tyrosine phosphorylation sites and palmitoylation sites
[16]. We constructed an amino-terminal fragment comprising 343
amino acids of AATYK1A (GST-N343) in which the (S/T)P
sequences were reduced to two. We incubated GST-N343 with
Figure 2. Colocalization of p35 with AATYK1A in early and recycling endosomes. (A) Colocalization of AATYK1A and p35 in COS-7 cells.
COS-7 cells were transfected with AATYK1A-Myc together with p35 and Cdk5. AATYK1A and p35 were detected by immunostaining with the anti-Myc
antibody and anti-p35 antibody, followed by incubation with Alexa 488-conjugated anti-mouse IgG and Alexa 548-conjugated anti-rabbit antibody,
respectively. A merged image is shown in the right panel. Insets represent higher magnifications and arrows indicate the colocalization. Scale bar,
20 mm. (B) Localization of AATYK1A and p35 in early and recycling endosomes. COS-7 cells were transfected with AATYK1A-Myc, p35, Cdk5, and either
EGFP-Rab5A (as an early-endosome marker) or EGFP–Rab11A (as a recycling-endosome marker). After 24 h of transfection, cells were fixed and
stained with anti-Myc and anti-p35 antibodies, as described above, and were observed using a confocal microscope. Scale bar, 10 mm. (C) Localization
of AATYK1 and p35 in endosomes in cultured cortical neurons. Rat brain cortical neurons at DIV5 were transfected with EGFP-Rab11A (middle panels).
The cells were immunostained with anti-AATYK1 and p35 (C19) 24 h after transfection, followed by Alexa 546-conjugated anti-rabbit secondary
antibody (left panels). Merge is shown in right panels. Bar, 10 mm.
doi:10.1371/journal.pone.0010260.g002
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32P]ATP (Fig. 3D). GST-N343
was phosphorylated. In contrast, its Ala mutant at Ser34 (S34A)
was not phosphorylated (Fig. 3D, lane 2). The Ala mutant at
Thr149 was phosphorylated by Cdk5/p35, similarly to the
unmutated fragment (Fig. 3D, lane 3), which indicates that
Ser34 is a Cdk5 phosphorylation site in N343.
In vivo phosphorylation at Ser34 of AATYK1
To investigate the in vivo phosphorylation of Ser34 of
AATYK1A, we raised a phospho-specific AATYK1A antibody
using a synthetic phosphopeptide corresponding to mouse
AATYK1A residues around Ser34 (Fig. 4A, underlined). The site
was conserved among the mammalian AATYK1A of mouse, rat,
and humans, although the amino-terminal amino acids of human
AATYK1A were somewhat different from those of mouse and rat
AATYK1A. The anti-pSer34 antibody reacted with AATYK1A
(Fig. 4B, arrowheads in lanes 2 and 3) but not with the S34A
mutant in COS-7 cells (Fig. 4B, lanes 4 and 5). The fact that
AATYK1A S34A was also shifted upward after cotransfection
with Cdk5/p35 implies that AATYK1A should have other Cdk5
phosphorylation site(s), in addition to Ser34 (Fig. 4B, lane 5). The
faint bands around AATYK1A S34A were nonspecific reactions,
which were also found in untransfected COS-7 cells (Fig. 4B, lane
1). The reaction to AATYK1A was remarkably enhanced by
coexpression with Cdk5/p35 (Fig. 4B, lane 3). Next, we addressed
Ser34 phosphorylation in neuronal cells. For this, we chose
PC12D cells, which express both Cdk5/p35 and AATYK1 [1,21].
PC12D cells, a subclone of PC12 cells, extend neurites more
promptly in response to nerve growth factor (NGF) [22,23]. We
use the term AATYK1 henceforth for endogenous AATYK1 in
PC12D cells and brains, as AATYK1A is not distinguishable from
AATYK1B using immunoblotting or immunofluorescent staining.
AATYK1 and its Ser34 phosphorylation were detected in PC12D
cells before NGF application (Fig. 4C, lane 1); however, NGF
treatment increased the expression and phosphorylation of
AATYK1 significantly (Fig. 4C, lane 2). Roscovitine suppressed
the phosphorylation of Ser34 and the electrophoretic mobility shift
of AATYK1 (Fig. 4C, lanes 3 and 4). The localization of
Figure 3. Phosphorylation of AATYK1A at Ser34 by Cdk5. (A) In vitro phosphorylation of AATYK1A by Cdk5/p35. AATYK1A-Flag was expressed
in HEK293 cells and isolated by immunoprecipitation using the anti-Flag antibody. AATYK1A-Flag was incubated with Cdk5/p35 and [c-
32P]ATP in the
presence or absence of 50 mM roscovitine (Ros) at 35uC for 30 min. The arrowhead indicates the phosphorylation of AATYK1A. (B) Dephosphorylation
of AATYK1A by treatment with alkaline phosphatase. AATYK1A-Flag expressed in the presence (+) or absence (–) of Cdk5/p35 in HEK293 cells was
isolated by immunoprecipitation using the anti-Flag antibody. Immunoprecipitates were treated with bacterial alkaline phosphatase (BAP) at 37uC for
30 min and immunoblotted with the anti-Flag antibody. (C) Phosphorylation of amino-terminal fragments of AATYK1A by Cdk5. The full-length (FL)
and amino-terminal fragments of AATYK1A-Myc, N1130, N667, and N530, were expressed in HEK293 cells in the presence (+) or absence (–) of Cdk5/
p35. HEK293 cell extracts were immunoblotted using the anti-Myc antibody. (D) Ser34 is a Cdk5 phosphorylation site of AATYK1A. The GST-N343
fragment or its Ala mutant at Ser34 (S34A), Thr149 (T149A), or both (2A) was incubated with purified Cdk5/p35 in the presence of [c-
32P]ATP at 35uC
for 30 min. Phosphorylation was detected using autoradiography after SDS–PAGE. Coomassie Brilliant Blue (CBB) staining of GST-N343 is shown in
the lower panel.
doi:10.1371/journal.pone.0010260.g003
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immunostaining of transfected PC12D cells, in which we could
obtain specific staining with anti-pSer34 antibody. Phospho-
AATYK1A was strongly detected at the growth cones of extended
neurites and in the cell body of NGF-treated cells (arrow in
Fig. 4D). These results indicate that Cdk5 phosphorylates
AATYK1 at Ser34 at the tip of neurites in PC12D cells.
The anti-pS34 antibody recognized AATYK1 immunoprecip-
itated from a mouse brain extract at a molecular weight
,200 KDa (Fig. 5A, lane 1). Dephosphorylation with alkaline
phosphatase abolished this reaction (Fig. 5A, lane 2), indicating
that AATYK1 is phosphorylated at Ser34 in mouse brain.
Expression of AATYK1 increased gradually from P2 to adult
age (10 weeks). Ser34 phosphorylation was also detected in brains
at P2 and decreased by P10, when normalized to the expression
levels of AATYK1 (Fig. 5B).
To confirm that Cdk5 phosphorylated AATYK1 at Ser34 in
vivo, we examined the phosphorylation of AATYK1 in Cdk5-
deficient mouse brains. Interestingly, expression of AATYK1 was
increased by 1.43-fold in Cdk5-deficient brain compared with
wild-type mouse brain (Fig. 5C, lanes 2 and 4; and Fig. 5D). In
Cdk5-deficient brain, AATYK1 exhibited increased electropho-
retic mobility (Fig. 5C) and decreased immunoreactivity to the
anti-pS34 antibody (Fig. 5C and E), which suggests that Cdk5
phosphorylates Ser34 of AATYK1 in the mouse brain.
Ser34 phosphorylation inhibited the tyrosine
phosphorylation of AATYK1A
We reported previously on the Fyn- or Src-mediated tyrosine
phosphorylation of AATYK1A [16]. We hypothesized that Cdk5-
mediated phosphorylation of AATYK1A inhibits its tyrosine
phosphorylation. The coexpression of AATYK1A with Cdk5/p35
in COS-7 cells led to a significant decrease in the pervanadate-
induced tyrosine phosphorylation of AATYK1A (Fig. 6A, lane 3).
The effect of Cdk5 activity on tyrosine phosphorylation is clearly
shown in Fig. 6B, in which wild type or kinase negative (kn) Cdk5
was coexpressed with AATYK1A. Coexpression of knCdk5
increased tyrosine phosphorylation together with decreased
Ser34 phosphorylation. To identify the tyrosine phosphorylation
sites, we analyzed the tyrosine phosphorylation of several deletion
mutants of AATYK1A, N667, DKD, and N390, which were
coexpressed with Cdk5/p35 (Fig. 6C, left panel). Inhibition of
tyrosine phosphorylation was observed for all deletion mutants of
AATYK1A (Fig. 6C, right panel), which suggests the presence of
tyrosine phosphorylation site(s) in N390. To confirm that Ser34
phosphorylation inhibited the tyrosine phosphorylation of AA-
TYK1A, N390 or its Ala mutant at Ser34 (N390-S34A) was
expressed together with Cdk5/p35 in COS-7 cells and their
tyrosine phosphorylation was examined after pervanadate treat-
ment (Fig. 6D). Inhibition of tyrosine phosphorylation was
observed exclusively for N390 coexpressed with Cdk5/p35 (and
Figure 4. Generation of the anti-pSer34-specific antibody and Ser34 phosphorylation of AATYK1 in PC12D cells. (A) Amino-acid
sequences of mouse, rat, and human AATYK1A around Ser34. A synthetic peptide corresponding to the mouse AATYK1A amino-acid residues 29–39
(the Ser34 phosphorylation site is underlined) was used for rabbit immunization. (B) Specificity of the anti-pS34 antibody. COS-7 cells were
transfected with AATYK1A or its S34A mutant in the presence (+) or absence (–) of Cdk5/p35. Cell extracts were immunoblotted with the anti-pS34
antibody or anti-Myc antibody for AATYK1A. (C) Phosphorylation of AATYK1 at Ser34 in PC12D cells. PC12D cells were treated with 50 ng/ml NGF for
24 h in the presence or absence of 20 mM roscovitine (Ros). AATYK1 was immunoprecipitated in PC12D cells using the anti-AATYK1 antibody and was
subjected to immunoblotting with the anti-pS34 or anti-AATYK1 antibodies. (D) Immunofluorescent staining of PC12D cells using the anti-pS34
antibody. PC12D cells expressing AATYK1A-Myc were treated with NGF for 24 h and double labeled with the anti-pS34 (top panel) and anti-Myc
(AATYK1A, middle panel) antibodies. A merged image is shown in the lower panel. The growth cone is indicated by an arrow. Scale bar, 20 mm.
doi:10.1371/journal.pone.0010260.g004
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mediated Ser34 phosphorylation suppresses the tyrosine phos-
phorylation of AATYK1A at tyrosine residues located in N390.
Discussion
We investigated the interaction of AATYK1A, a major isoform
of AATYK1 that is expressed in brain, with Cdk5/p35. We
observed the in vivo binding of AATYK1A to Cdk5/p35 using anti-
AATYK1 coimmunoprecipitation from HEK293 cell extracts and
mouse brain extracts. In COS-7 cells, these proteins colocalized in
early and recycling endosomes labeled with Rab5A and Rab11A,
respectively. Cdk5/p35 phosphorylated AATYK1A at Ser34 in
vitro and in vivo. This Cdk5-mediated phosphorylation decreased
the tyrosine phosphorylation of AATYK1A. Considering that
AATYK2/cprk, a member of the AATYK family that exhibits a
Cdk5-phosphorylation-mediated decrease in tyrosine phosphory-
lation, is involved in endosomal trafficking, the Ser34 and/or
tyrosine phosphorylation of AATYK1A may also play a role in
regulating endosomal-membrane and -protein transport.
The observation of cellular colocalization and physical binding
are required to demonstrate a cellular interaction between two
components. AATYK1A binds to membranes via palmitoylation
at its three amino-terminal cysteine residues [16] and Cdk5/p35
associates with membranes via myristoylation of p35 [18,19].
Although both proteins localize in the perinuclear region, the
precise organelles where they reside are different; AATYK1A is
located in recycling endosomes [16] and Cdk5/p35 is located in
the Golgi apparatus [17,18]. We examined the cellular localization
of AATYK1A previously using various endosomal and Golgi
markers and showed its presence mainly in Rab11A-positive
recycling endosomes (but not in the Golgi) [16]. In contrast, the
localization of Cdk5 in endosomes has not been examined,
although its association with Golgi and plasma membranes has
been demonstrated. Here, the coexpression of these two proteins
in COS-7 cells allowed us to confirm that they colocalized in early
Figure 5. Cdk5-mediated in vivo Ser34 phosphorylation. (A) Phosphorylation of AATYK1 in mouse brain. AATYK1 was immunoprecipitated
from mouse brain extracts and incubated in the presence (+) or absence (–) of bacterial alkaline phosphatase (BAP). The anti-pS34 reaction is shown
in the upper panel and the anti-AATYK1 reaction is shown in the lower panel. (B) Phosphorylation of AATYK1 in mouse brain during early postnatal
development. AATYK1 was immunoprecipitated from mouse brain extracts at P2, P5, P10, and six weeks of age (Ad) using the anti-AATYK1 antibody.
The immunoprecipitates were immunoblotted using the anti-pS34 (top panel) and anti-AATYK1 (second panel) antibodies. Immunoblots of brain
extracts using anti-AATYK1 and anti-actin antibodies are also shown in the lower panels. (C) Phosphorylation of AATYK1 at Ser34 in Cdk5
–/– mouse
brain. AATYK1 was immunoprecipitated from brain extracts of Cdk5
–/– mice at embryonic day 18.5 (E18.5) and immunoblotted using the anti-pS34
antibody (top panel). Immunoblots of the brain extracts using anti-AATYK1 (third panel), anti-Cdk5 (fourth panel), and anti-actin (bottom panel)
antibodies. Quantification of AATYK1 and pS34 is shown in (D) and (E), respectively. Bars indicate the means 6 S.E. of three independent experiments
(n=3; * P,0.05; t test).
doi:10.1371/journal.pone.0010260.g005
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distributed widely in various membranous compartments, may
associate with AATYK1A in early-to-recycling endosomes.
Cdk5/p35 phosphorylated AATYK1A in vitro and in vivo. The
phosphorylation of AATYK1 was increased in PC12D cells after
NGF treatment, which stimulates Cdk5 activity, and was elevated
in mouse brains during early postnatal days, when Cdk5 activity is
high. AATYK1A is a large protein that comprises 1,317 amino
acids and contains 36 (S/T)P Cdk5 phosphorylation consensus
sequences, most of which are located in the carboxy-terminal tail
domain. We observed that the middle and tail regions of
AATYK1A were phosphorylated by Cdk5/p35 (data not shown),
which suggests that some of these carboxy-terminal (S/T)P sites
may be phosphorylated by Cdk5/p35. The finding that
AATYK1A S34A was shifted upward after coexpression with
Cdk5/p35 in COS-7 cells is consistent with this idea. However, we
focused on the amino-terminal phosphorylation of AATYK1A
because the amino-terminal region upstream from the kinase
domain seems to be one of the important functional domains of
AATYK1A, as it contains the palmitoylation sites Cys 4, 6, and 7
and the tyrosine phosphorylation sites Tyr25 and Tyr46 [16]. The
Cdk5-phosphorylation site (Ser34) lies between the two Tyr
phosphorylation sites. Notably, Cdk5-mediated Ser34 phosphor-
ylation suppressed the tyrosine phosphorylation of AATYK1A.
Although we did not determine whether phosphorylation at these
Tyr residues is affected by Cdk5 phosphorylation at Ser34, this
seems likely, as suppression of tyrosine phosphorylation occurred
in the amino-terminal fragment N390. Introduction of a negative
charge into Ser34 may affect subsequent phosphorylation at Tyr
residues, which are close to Ser34. These results suggest that Cdk5
and Src family kinases (SFKs) may interplay on AATYK1A in
endosomes.
It may be worth pointing out some similarities between
AATYK1A and AATYK2, which is also known as LMTK2/
KPI-2/BREK/cprk [4,5,6], regarding several of the properties
described here. AATYK2/cprk was isolated as a p35-binding
protein using a yeast two-hybrid system [5], as was the case for
AATYK1 [15]. The p35-binding region of both AATYK1A and
AATYK2/cprk is adjacent to the kinase domain in the carboxy
terminal, which exhibits some amino-acid sequence similarity [1].
AATYK2/cprk is phosphorylated by Cdk5/p35 [5]. This
phosphorylation by Cdk5/p35 also reduces the tyrosine phos-
Figure 6. Phosphorylation of AATYK1A by Cdk5 suppressed its tyrosine phosphorylation. (A) Effect of Cdk5/p35 on the tyrosine
phosphorylation of AATYK1A. AATYK1A-Flag was transfected into HEK293 cells, alone or with Cdk5/p35. Twenty-four hours after transfection, cells
were treated with 50 mM pervanadate for 20 min. AATYK1A was immunoprecipitated with the anti-Flag antibody and examined for tyrosine
phosphorylation using immunoblotting with the anti-phospho-Tyr antibody (pY). (B) COS-7 cells expressing AATYK1A and Cdk5/p35 or knCdk5/p35
were treatment with 100 mM pervanadate for 5 min. After immunoprecipitation with the anti-AATYK1A antibody, their tyrosine phosphorylation was
examined using the anti-phospho-Tyr antibody (pY) and Ser34 phosphorylation was detected in the immunoprecipitates with anti-pS34 antibody. (C)
Tyrosine phosphorylation of AATYK1A and of its deletion mutants, N677, DKD, or N390. AATYK1A or its deletion mutants was transfected into COS-7
cells, alone (–) or with Cdk5/p35 (+). After treatment with 100 mM pervanadate for 5 min, the tyrosine phosphorylation of AATYK1A was examined
after immunoprecipitation with the anti-Myc antibody. (D) N390 or N390-S34A (S34A) was expressed in COS-7 cells, alone (–) or with Cdk5/p35 (+).
Tyrosine phosphorylation was induced by the pervanadate treatment at 100 mM for 5 min. After immunoprecipitation with the anti-Myc antibody,
their tyrosine phosphorylation was examined using the anti-phospho-Tyr antibody (pY).
doi:10.1371/journal.pone.0010260.g006
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based on the decreased kinase activity of AATYK2/cprk, as
AATYK2/cprk was suspected to be a tyrosine kinase at the time.
However, AATYK2/cprk is now known as a Ser/Thr kinase
[4,6,24]. Although it remains unknown whether the amino-
terminal end of the kinase domain of AATYK2/cprk is
phosphorylated, as is that of AATYK1A, there are several possible
(S/T)P Cdk5 phosphorylation sites in the region corresponding to
Ser34 of AATYK1A. The reduced tyrosine phosphorylation of
Cdk5-phosphorylated AATYK2/cprk could be also due to
phosphorylation by other Tyr kinases, such as SFKs.
Ablation of AATYK2/cprk using an siRNA approach disrupts
the transport of endocytosed membranes from early to recycling
endosomes [25,26], which suggests a function for AATYK2/cprk
in endosomal trafficking. In fact, we have recently observed that
AATYK1A plays a role in accumulation of recycling endosomes in
pericentrosomal compartment in CHO-K1 cells and phosphory-
lation at Ser34 inhibits its activity (Takano et al., unpublished
observation). Interestingly, AATYK1A accumulated in the growth
cones of neurites in PC12D cells. Recycling endosomes contribute
the membranes and protein trafficking required for neurite
outgrowth [27,28]. On the other hand, Cdk5 suppresses exocytosis
of neurotransmitters by preventing Ca
2+ entry via P/Q type Ca
2+
channels and suppresses endocytosis of released neurotransmitters
via the phosphorylation of dynamin 1 and amphiphysin 1 at the
presynaptic terminus [29,30,31]. Intracellular vesicle transport
uses molecular machinery that is similar to that used in endocytosis
and exocytosis. Taking into consideration the association of Cdk5/
p35 with cytoplasmic organelles, including early and recycling
endosomes, Cdk5/p35 may also participate in vesicle transport.
Cdk5/p35 activity is required for neurite outgrowth in cultured
neurons and in PC12 cells [24,32]. Cdk5/p35 and/or SFKs may
regulate AATYK1A function in endosomal trafficking via
phosphorylation at its Ser34 residue.
Materials and Methods
Ethics Statement
Mice were handled in accordance with Riken BSI guidelines
and housed in a pathogen-free environment on a 12 h light/dark
cycle.
Chemicals, antibodies, and plasmids
Leupeptin was obtained from the Peptide Institute (Osaka,
Japan), 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride
(AEBSF or Pefabloc) and Roscovitine were purchased from Wako
(Osaka, Japan), and Dulbecco’s modified Eagle’s medium (D-
MEM) and nerve growth factor (NGF) were from Sigma (St.
Louis, MO). The PolyFect transfection reagent was obtained from
Qiagen (Hilden, Germany) and Lipofectamine 2000 was from
Invitrogen (Carlsbad, CA).
The antibodies used in this study were as follows: anti-Flag (M2)
and anti-actin (Sigma); monoclonal (9E10) and polyclonal anti-
Myc, anti-p35 (C-19), and anti-Cdk5 (DC17) (Santa Cruz
Biotechnology, Santa Cruz, CA); Alexa 488-, 546-, and 647-
conjugated secondary antibodies to mouse or rabbit IgG
(Invitrogen); and anti-phospho-Tyr (4G10) (Upstate Biotechnolo-
gy, Lake Placid, NY). The anti-AATYK1 antibody was described
previously [16]. The anti-phospho-Ser34 (anti-pS34) antibody for
AATYK1 was generated via immunization of rabbits with the
pSer34 peptide FSEQGpSPAAAAC conjugated to keyhole limpet
hemocyanin. The resulting antibody was affinity purified using a
nonphosphorylated peptide-conjugated column negatively and a
phosphorylated peptide-conjugated column positively.
The mammalian cell-expression plasmids used in this study
were as follows: AATYK1A-Flag and AATYK1A-Myc-His [16],
pCMV5-Cdk5 and pCMV5-p35 [33], and EGFP-Rab5A and
EGFP-Rab11A [34,35]. The Ala mutants of AATYK1 at Ser34 or
Thr149 were constructed using the QuikChange Site-Directed
Mutagenesis kit (Stratagene, La Jolla, CA), according to the
manufacturer’s protocol. GST-N343, which consisted of AA-
TYK1A amino-acid residues 1–343 (N343), was inserted into
pGEX 4T-1 (GE Healthcare) after PCR amplification using the
AATYK1A cDNA as a template.
In vitro phosphorylation
Cdk5/p35 was purified from Sf-9 cells [36]. AATYK1A-Flag or
GST-N343 was incubated with Cdk5/p35 in kinase buffer
(10 mM MOPS, pH 6.8, 2 mM MgCl2, 0.1 mM EGTA, and
0.1 mM EDTA) in the presence of 0.1 mM [c-
32P]ATP for
30 min at 35uC. Phosphorylation was detected using autoradiog-
raphy after SDS–polyacrylamide gel electrophoresis (PAGE).
Tyrosine phosphorylation of the AATYK1A constructs was
assessed in COS-7 cells using immunoblotting with the anti-
phospho-Tyr (4G10) antibody after immunoprecipitation.
Cell culture, transfection, and immunoprecipitation
HEK293 and COS-7 cells were maintained in D-MEM
containing 10% fetal bovine serum, 100 U/ml penicillin, and
0.1 mg/ml streptomycin [18]. Transfection into COS-7 cells or
HEK293 cells was performed using the PolyFect transfection
reagent or Lipofectamine 2000, according to the manufacturer’s
instructions. PC12D cells, which were provided by Dr. Mamoru
Sano from the Kyoto Prefectural University of Medicine, were
maintained in D-MEM containing 10% fetal bovine serum, 5%
horse serum, 100 U/ml penicillin, and 0.1 mg/ml streptomycin
[22,23]. Transfection into PC12D cells was performed using
Lipofectamine 2000. Brains of postnatal day 2 (P2) to six-weeks-
old ICR mice (Japan SLC, Shizuoka Japan) were homogenized in
HEPES buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM
MgCl2, 1 mM EGTA, 0.4 mM AEBSF, 10 ug/ml leupeptin, and
0.5% Nonidet P-40) and AATYK1 was immunoprecipitated using
the anti-AATYK1 antibody. Cerebral cortical neurons were
prepared from rat brains at embryonic day 18 as described
previously [36]. Cdk5-deficient mice were generated and main-
tained as described previously [37,38].
Immunofluorescent staining and observation
Cells were fixed with 4% paraformaldehyde in phosphate-
buffered saline (PBS) for 20 min and permeabilized with 0.1%
Triton X-100 in PBS containing 5% normal goat serum. Cells
were probed with primary antibodies for 1 h at room temperature
or overnight at 4uC. After washing with PBS, cells were stained
with Alexa-conjugated secondary antibodies. Fluorescent images
were acquired using an LSM5 EXCITER confocal laser-scanning
microscope (Carl Zeiss, Oberkochen, Germany).
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